News

Fight for Sight has awarded six £15,000 grants to support ophthalmic research in the UK.

Implanatation of multiple trabecular micro-bypass implants (iStent, Glaukos) in Schlemm's canal following phamoemulsification successfully and significantly reduced IOP for 12 months after implantation, as well as the number of medications required to maintain target IOP

Several algorithms help physicians base appropriate therapy on signs and symptons

Analyses of data from the Confocal Scanning Laser Ophthalmoscopy Ancilliary Study to the Ocular Hypertension Treatment study found rim area parameters changed significantly in the eyes that had progression to a primary open-angle glaucoma endpoint compared with eyes that did not.

Dr Zaluski examines the visual performance and ascertains the level of patient satisfaction with the multifocalDiffractiva Diff-s IOL

It has been demonstrated that autorefractometry is less accurate in eyes that have undergone LASIK when compared with non-operated eyes, according to a recent study published in the American Journal of Ophthalmology.

The potential complications associated with implantation of phakic IOLs may give cataract surgeons a few challenges, but problems can often be averted with proper sizing and vaulting.

Looking into post-injection endophthalmitus, which has become one of the most frequent causes of endophthalmitus.

A rare case of bilateral pigmented atrophic changes in the macular region associated with topiramate treatment for chorioathetosis in a young female is reported.

A new variation of femtosecond laser-assisted 'big bubble' deep anterior lamellar keratoplasty uses the laser to create an intrastromal channel serves as a pathway for the insertion of the air injection

A round up of new products

Avoiding permanent damage calls for more aggressive treatment, occasional 'scare' tactic

A review of the year in cataract & refractive, retina and glaucoma. Shows three industry experts view on their highs of the year and the changes they've experienced as well as what the future holds for 2011

Results from preclinical testing including a formal Good Laboratory Practice toxicity study, support the safety of a gene transfer agent, AAV2-sFLT01, when administered intravitreally. A phase I safety and tolerability study of this agent is currently underway.

Patients suffering from primary open-angle glaucoma (POAG) or ocular hypertension have been shown to respond better to travoprost than latanoprost according to a recent study.

Optos plc has announced its proposed acquisition of the entire issued shared capital of Opto Global Holdings for up to $14.75 million.

Volk Optical has expanded its disposable vitrectomy lens range with five new direct image lenses.

Summary

A recent study has shown that the AcrySof toric IOL is more stable and provides better vision in cataract patients with pre-existing astigmatism, compared with an AcrySof spherical IOL.

A pain relief drug (+)-pentazocine has been shown to restore retinal health in diabetic mice. It is now hoped that this action can be replicated in humans.

Corneal arcus has been associated with higher intraocular pressure (IOP) and lower central corneal thickness (CCT), according to a recent study.

i-Optics has announced the successful closure of its third financing round with an investment of €4.2 million, which will enable the company to launch its first product for 2011 early

The presence of cataracts has been shown to influence OCT image quality.

The FDA has cleared an age-adjusted retinal nerve fibre layer thickness normative database for a proprietary ocular coherence tomography (OCT) device, Spectralis (Heidelberg Engineering).

A subretinal implant has been shown to restore some vision in patients blinded by hereditary retinal degeneration.

Spectacle correction improves distance vision during night-time driving in presbyopes but has a negative impact on near vision.

The ACI 7000 corneal inlay has shown safety and efficacy over a two-year study period in presbyopia patients, according to a study published in the Journal of Refractive Surgery.

A recent study revealed a novel push-pull training protocol that was designed to reduce sensory eye dominance (SED).

Curcumin-based treatment Norflo, has been shown to alleviate the symptoms of anterior uveitis in a recent study published in Clinical Ophthalmology, indicating a potential role for the anti-inflammatory treatment curcumin in eye inflammatory and degenerative conditions.

Pfizer has announced that Xalatan (latanoprost) has been approved by the European Commission for the reduction of elevated IOP in the treatment of paediatric patients.